Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
<h4>Background</h4>Gliosarcoma is one of the most common malignant brain tumors, and anti-angiogenesis is a promising approach for the treatment of gliosarcoma. However, chemotherapy is obstructed by the physical obstacle formed by the blood-brain barrier (BBB) and blood-cerebrospinal fl...
Guardado en:
Autores principales: | Xianhuo Wang, Xingmei Duan, Guangli Yang, Xiaoyan Zhang, Linyu Deng, Hao Zheng, Chongyang Deng, Jiaolin Wen, Ning Wang, Cheng Peng, Xia Zhao, Yuquan Wei, Lijuan Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dece1e78bedd4ac4bc8ff29f1753f881 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hypermutated phenotype in gliosarcoma of the spinal cord
por: Christopher S. Hong, et al.
Publicado: (2021) -
Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases
por: Xingchi Chen, et al.
Publicado: (2021) -
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations
por: Mark M. Zaki, et al.
Publicado: (2021) -
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
por: Y. Anraku, et al.
Publicado: (2017) -
Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
por: Adriana Trifan, et al.
Publicado: (2021)